NewAmsterdam Pharma Company N.V.

NAMS | NASDAQ | 0 Followers
$17.88 -0.45% -$0.08
Follow
Loading...

Profile

NewAmsterdam Pharma Company N.V. is a Dutch biotechnology company focused on the development of innovative therapeutic drugs for the treatment of cardiometabolic and liver diseases. The company specializes in research and development of drugs that target specific biological pathways related to these conditions, including treatments for high cholesterol, liver cirrhosis, and other chronic diseases. NewAmsterdam Pharma focuses on providing effective therapeutic options that can improve the health of patients suffering from these complex diseases.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade